Gsk-J4

CAS No.

1373423-53-0

MDL No.

MFCD22683852

C₂₄H₂₇N₅O₂

417.50

InChI Key

WBKCKEHGXNWYMO-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

3-[[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid ethyl ester is an organonitrogen heterocyclic compound.

CAS No.	1373423-53-0
Product Name	Gsk-J4

Irritant

Signal Word:Warning

HCode:H315-H319-H335

PCode:P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Pricing & Availability

Product Information

Safety Information

Properties

Documentation

Gsk-J4

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

JMJD3 downregulates IL4i1 aggravating lipopolysaccharide-induced acute lung injury via H3K27 and H3K4 demethylation.

Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells.

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells.

Documentation